Industry Analysis & Industry Trends
Brand-name pharmaceutical manufacturers have grappled in recent years with one of the largest waves of drug patent expirations in history. As this so-called patent cliff occurred, many blockbuster drugs lost patent exclusivity, allowing low-price generic drugs to inundate the market. As a result, many brand-name pharmaceutical manufacturers have dealt with intensifying competition from generic manufacturers, cutting into revenue growth. In the coming years, brand-name pharmaceutical manufacturers will exhibit growth due to strong consumer demand for biologic drugs... purchase to read more
Industry Report - Industry Products Chapter
Within brand-name pharmaceuticals and medicines, there are four main product categories: pharmaceutical preparation products (preparations); medicinal and botanical products; biologic products; and in-vitro diagnostic substance products. However, industry products are broken down by therapeutic area.
Oncology and antidiabetic products
In 2015, oncology and antidiabetic products are expected to make up 10.8% and 9.4% of industry revenue, respectively. In the United States, 1.6 million new cancer cases are expected to occur in 2015, according to the American Cancer Society. Prostate cancer is common among men, with women having a relatively high incidence of breast cancer. High cancer drug prices have constrained patients' access to these drugs... purchase to read more